NEU1 and metabolic disease: Altogether, these studies indicate that NEU-1 plays a key role not only in the development of several cancers but also in metabolic disorders, which make NEU-1 a pharmacological target of high potential in these physiopathological contexts (Figure 1) [26,27,28,29].